GNA Biosolutions is a private molecular diagnostics company.
GNA Biosolutions has raised €12M across 1 funding round from 1 investor, most recently a Series C round in Jul 2019. Based in Munich, Germany; founded 2010; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-07-01 | Series C |
| €12M |
| GreyBird Ventures |
| View deal → |
